PET/CT with breast MR helps determine response to chemotherapy

06/12/2013 | MolecularImaging.net

PET/CT with breast MR imaging allowed physicians to determine the effectiveness of neoadjuvant chemotherapy before surgery in women with advanced breast cancer, according to findings presented at the SNMMI Annual Meeting. "Together these techniques can help clinicians classify patients and provide risk stratification to not only predict cancer recurrence after treatment but also avoid chemotherapy for those who probably would benefit more from an alternative treatment," said Dr. Sang Moo Lim from the National Radiation Emergency Medical Center of the Korea Institute of Radiological and Medical Sciences in Seoul.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY